Dmitry D. Procenko

Dmitry D. Procenko

Auto-generated profile, based on publicly available information

Dmitry D. Procenko

Sechenov University

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Russian Journal of Forensic Medicine
Verified
Journal Article
Open access
PDF file
KEKogan Evgenija
Kogan Evgenija
YBYuri Berezovskij
Yuri Berezovskij
DPD. D. Protsenko
D. D. Protsenko
TBT. R. Bagdasaryan
T. R. Bagdasaryan
EGE. M. Gretsov
E. M. Gretsov
ЮБЮ. С. Березовский
Ю. С. Березовский
Autopsy data from 80 patients who died of the COVID-19 infection were analysed. Using macro- and microscopic studies, specific features of pathological processes in various organs were identified. The obtained experimental data, along with information from literature sources, allowed conclusions to be drawn about the mechanisms of damaging internal organs and body systems, as well as assumptions to be made about individual links in the pathogenesis of COVID-19. The thanatogenesis of the disease and the main causes of death are discussed, including acute cardiopulmonary failure, acute renal failure, pulmonary thromboembolism, shock involving multiple organ failure and sepsis. The critical importance of autopsy is emphasized, which provides valuable information on the morphological substrate for this infection closely associated with possible clinical manifestations.

17 October 2020 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
OLO. A. Lobanova
O. A. Lobanova
DTD. S. Trusova
D. S. Trusova
ERE. E. Rudenko
E. E. Rudenko
DPD. D. Protsenko
D. D. Protsenko
KEKogan Evgenija
Kogan Evgenija
On March 11, 2020, the World Health Organization declared COVID-19 apandemic. Despite a large number of scientific publications concerning the clinical picture and trea tment methods, data on structural changes of internal organs in COVID-19 is still insufficient. This review presents and analyzes several clinical cases published by research groups in various countries. COVID-19 infection is caused by a SARS-CoV-2 virus that binds to the angiotensin-converting enzyme 2 ACE2 receptor. Interaction with this receptor is the initial stage of pathogenesis. The morphological picture is similar to pneumonia caused by SARS-CoV and MERS-CoV: at the initial stage, a picture of shock lungs develops, later it ends in fibrosis and organizing pneumonia. One of the most severe complications is acute respiratory distress syndrome, which is observed in some clinical cases reviewed. In this article, we collected cases of clinical and morphological studies of patients with COVID-19, published in international peer-reviewed medical literature to date.

22 September 2023 in Clinical Medicine (Russian Journal)
Verified
Journal Article
Open access
PDF file
ASA. A. Sheptulin
A. A. Sheptulin
OSO. A. Storonova
O. A. Storonova
PPP. V. Pavlov
P. V. Pavlov
ATAlexander Tertychnyy
Alexander Tertychnyy
DPD. D. Protsenko
D. D. Protsenko
XFX. V. Feoktistova
X. V. Feoktistova
The article discusses the controversial terminology of biliary refl ux gastritis and the factors predisposing to its occurrence. Pathogenesis of this disease includes 2 main components: disorders of motility of the stomach and duodenum, leading to duodeno-gastric refl ux, and direct damaging eff ect of hydrophobic bile acids and lysolecithin on the protective barrier of the stomach mucosa. Clinical picture of biliary refl ux gastritis is nonspecifi c and most often corresponds to dyspepsia syndrome. Esophagogastroduodenoscopy with biopsy and subsequent histological examination, 24-hour pH-metry of the stomach, monitoring of bilirubin level in gastric contents are used in diagnostics of this disease. Treatment of biliary refl ux gastritis includes prescription of ursodeoxycholic acid, prokinetics, antacids, proton pump inhibitors, cytoprotectors. Given the insuffi cient study and controversial coverage of many aspects of biliary refl ux gastritis, this problem requires further research.

11 September 2023 in Russian Journal of Gastroenterology, Hepatology, Coloproctology
Verified
Journal Article
Open access
PDF file
ATAlexander Tertychnyy
Alexander Tertychnyy
NPNano Pachuashvili
Nano Pachuashvili
DND. P. Nagornaya
D. P. Nagornaya
TLT. L. Lapina
T. L. Lapina
ELE. A. Losik
E. A. Losik
VIVladimir Ivashkin
Vladimir Ivashkin
Аim: to analyze a series of cases of dysplasia and early gastric cancer developed in patients with autoimmune gastritis (AIG), and to identify their clinical and morphological features.Materials and methods. The study included six cases of detection of early gastric cancer on the background of AIG. Four out of six patients underwent endoscopic treatment, and in three out of six cases patients underwent endoscopic mucosectomy with dissection in the submucosal layer. One patient underwent endoscopic surgery in 2017, he continues annual dynamic follow-up without signs of tumour recurrence. A female patient with type 1 neuroendocrine tumour and mild dysplasia is awaiting treatment.Results. In five out of six patients with AIG, the localization of lesions prevailed in the stomach body, while all detected tumours were early ones, and according to the immunophenotype — of a gastric type. The presented cases of tumours were not accompanied by hyperplasia of neuroendocrine cells directly in the area of the tumour itself, but only in the surrounding gastric mucosa. Additionally, several cases of early gastrointestinal stromal tumours were found, which were characterized by low proliferative activity and had small sizes.Conclusion. The predominance of pseudopyloric metaplasia in the surrounding mucosa allows us to consider pseudopyloric metaplasia as a potentially significant change in the gastric mucosa of patients with AIG that may precede the development of gastric cancer.

31 July 2024 in Annals of Critical Care
Verified
Journal Article
Open access
PDF file
ADA. A. Dmitriev
A. A. Dmitriev
NTN. V. Trembach
N. V. Trembach
DPD. D. Protsenko
D. D. Protsenko
IZIgor B. Zabolotskikh
Igor B. Zabolotskikh
INTRODUCTION: Despite the introduction of the principles of multimodal analgesia, it is often necessary to use opioids to relieve pain, which, as is known, have a number of significant side effects. The domestic peptide opioid agonist tyrosyl-D-arginyl-phenylalanyl-glycin amide has been studied for a relatively short time, but has already proven itself well in the treatment of pain in cancer patients and in the postoperative period. OBJECTIVE: To study the effectiveness and safety of postoperative pain relief for gynecological laparoscopic surgery based on the use of the peptide tyrosyl-D-arginyl-phenylalanyl-glycin. MATERIALS AND METHODS: A randomized controlled trial was conducted in 118 gynecological patients who underwent laparoscopic surgery. The patients were randomly assigned to one of the groups: the patient of the main group, received tyrosyl-D-arginyl-phenylalanyl-glycin amide at a dose of 4 mg, subcutaneously, 3 times a day (group T); control group — placebo subcutaneously, 3 times a day (group C). The severity of pain syndrome according to numerical rating scale (NRS) and total pain relief in the first 6 hours (TOTPAR0-6) were assessed. RESULTS: The level of pain severity was statistically significantly lower in group T compared with the control group 30 minutes after the end of the surgery (2.98 ± 0.97 versus 3.66 ± 0.60, p < 0.0001), after 2 hours (2.50 ± 0.81 versus 3.47 ± 0.99, p < 0.0001) and after 6 hours (2.49 ± 0.80 versus 3.30 ± 0.88, p < 0.0001). The need for opiates was significantly lower in group T (14.15 ± 1.79 mg versus 16.08 ± 2.29 mg, p < 0.0001). The incidence of postoperative nausea and vomiting was one and a half times lower in the group T; among the adverse events, differences between the groups were identified in the incidence of hypoxemia. CONCLUSIONS: The use of tyrosyl-D-arginyl-phenylalanyl-glycin amide as a component of a multimodal postoperative pain management can reduce the severity of pain, reduce the need for narcotic analgesics and reduce the frequency of critical respiratory incidents. The use of the drug was not accompanied by an increase in adverse events.

31 July 2025 in Annals of Critical Care
Verified
Journal Article
Open access
PDF file
IZIgor B. Zabolotskikh
Igor B. Zabolotskikh
TMT. S. Musaeva
T. S. Musaeva
NTN. V. Trembach
N. V. Trembach
VKV. E. Khoronenko
V. E. Khoronenko
MMM. A. Magomedov
M. A. Magomedov
AKArtem Kuzovlev
Artem Kuzovlev
INTRODUCTION: Risk assessment and identification of the group of patients with a high probability of developing an unfavorable outcome is the basis for effective prevention of postoperative adverse events. OBJECTIVE: To determine the incidence, pattern, severity and day of development of postoperative complications in patients after elective abdominal surgery based on STOPRISK database analysis. METHODS: The data of 11 478 patients in the STOPRISK database were analyzed. Gender, age, comorbidity, anesthesia and operative characteristics were recorded in all patients after assessment of compliance with the inclusion criteria. In the postoperative period, 30-day complications according to European Society of Anaesthesiology и European Society of Intensive Care Medicine classification and mortality were recorded. RESULTS: Of the 11 478 patients, 521 (4.5 %) developed complications in the postoperative period and 71 (0.62 %) developed fatal complications. Thus, among cardiac complications, arrhythmias occurred predominantly on days 1–3, 4–5, and 6–8; non-fatal cardiac arrest, acute myocardial infarction, and pulmonary embolism were observed in almost every time period. An overwhelming number of cases of cardiogenic pulmonary edema and acute cerebral circulatory failure were detected in the 1–3 day postoperative period. Among respiratory complications (acute respiratory distress syndrome, pneumonia, acute respiratory failure) the greatest number occurred before 8 days. Infectious complications (wound infection, sepsis) predominantly developed on the 4th–8th day. Cerebral complications (delirium) and renal complications (acute kidney injury) — predominantly on day 1–3. Surgical complications (anastomosis failure, intestinal paresis, postoperative bleeding and wound edge divergence) — at all stages of observation, but predominantly on days 1–3 and 4–8. CONCLUSIONS: The most frequent complication in the general population was intestinal paresis, followed by wound infection, postoperative bleeding, pneumonia, and the least frequent complications were STEMI and non-fatal cardiac arrest. 62 % of complications were of severe degree (III and higher).